Alterations of the gene expression profile in renal cell carcinoma after treatment with the histone deacetylase-inhibitor valproic acid and interferon-alpha

Dual Regulatory Roles of Phosphatidylinositol 3-Kinase in IFN Signaling

(2014) S. Kaur et al.   JOURNAL OF IMMUNOLOGY

Chemokine Receptors Expression and Migration Potential of Tumor-infiltrating and Peripheral-expanded Vγ9Vδ2 T Cells From Renal Cell Carcinoma Patients

(2009) Emilie Viey et al.   JOURNAL OF IMMUNOTHERAPY

CCL25 and CCL28 promote α4β7-integrin-dependent adhesion of lymphocytes to MAdCAM-1 under shear flow

(2008) Alice Miles et al.   AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY

Valproic acid as epigenetic cancer drug: Preclinical, clinical and transcriptional effects on solid tumors

(2008) Alfonso Duenas-Gonzalez et al.   CANCER TREATMENT REVIEWS

Angiostatic immune reaction in colorectal carcinoma: Impact on survival and perspectives for antiangiogenic therapy

(2008) Elisabeth Naschberger et al.   INTERNATIONAL JOURNAL OF CANCER

Valproic acid blocks adhesion of renal cell carcinoma cells to endothelium and extracellular matrix

(2008) Jon Jones et al.   JOURNAL OF CELLULAR AND MOLECULAR MEDICINE

The histone deacetylase inhibitor valproic acid alters growth properties of renal cell carcinomain vitroandin vivo

(2008) Jon Jones et al.   JOURNAL OF CELLULAR AND MOLECULAR MEDICINE

Interferon Regulatory Factors IRF5 and IRF7 Inhibit Growth and Induce Senescence in Immortal Li-Fraumeni Fibroblasts

(2008) Q. Li et al.   MOLECULAR CANCER RESEARCH

UBE1L causes lung cancer growth suppression by targeting cyclin D1

(2008) Q. Feng et al.   MOLECULAR CANCER THERAPEUTICS

Präklinische Studien zum Einfluss des Tyrosinkinaseinhibitors AEE788 auf die Malignität des Nierenzellkarzinoms

(2008) S.A. Wedel et al.   UROLOGE